EMA to clin­i­cal tri­al spon­sors: Use your Covid-re­lat­ed flex­i­bil­i­ties in re­spond­ing to Ukraine cri­sis

Eu­rope’s drug reg­u­la­tor told clin­i­cal tri­al spon­sors that are deal­ing with the fall­out from the war in Ukraine to use what they’ve learned from Covid …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.